Endo International plc (ENDP) stock showed a turn of 14.89% in most recent week and accomplished -29.22% performance over the last one month. On average, equities analysts expect that Endo International PLC will post $3.52 earnings per share for the current year.
For the Current Quarter, the growth estimate for Endo International plc is -34.7%, while for the Next Quarter the stock growth estimate is -59.9%. BMO Capital Markets reiterated a "market perform" rating and set a $11.00 target price (down previously from $15.00) on shares of Endo International PLC in a research note on Friday, August 11th. Morgan Stanley reduced their price objective on Endo International PLC from $12.00 to $8.00 and set an equal weight rating for the company in a report on Thursday, August 10th. Zacks Investment Research upgraded Endo International PLC from a "sell" rating to a "hold" rating in a research report on Tuesday, May 2nd.
Other equities analysts have also issued reports about the company.
During last 5 trades the stock sticks nearly 14.89%.
Endo International PLC (ENDP) traded up 6.82% on Tuesday, reaching $8.14. The company exposed volatility of 5.97% over the past week and moving out to look at the previous month volatility move, the stock is at 5.72%. For the current year the company's revenue estimates are $3.47 Billion compared to low analyst estimates of $3.4 Billion and high estimates of $3.52 Billion according to the prediction of 18 analysts. This company shares are 44.04% off its target price of $12.56 and the current market capitalization stands at $1.95B.More news: Shame! Indore man punches & kicks woman in gym, recorded on camera
Company chares are trading at $8.72 which is well below $10.47, the stock's 50 day moving average and quite a bit below the 200 day moving average of $11.43.
Endo International PLC (NASDAQ:ENDP) last issued its quarterly earnings data on Tuesday, August 8th. The company reported the earnings of $0.93/Share in the last quarter where the estimated EPS by analysts was $0.73/share. It has a return on equity (ROE) of -174.50%. The company's past year sales total was 884340. During the same quarter in the prior year, the business earned $0.86 earnings per share. In contrast to the year ago quarter EPS was at 1.22.
While looking at the Stock's Performance, Endo International plc now shows a Weekly Performance of 9.57%, where Monthly Performance is -27.86%, Quarterly performance is -30.51%, 6 Months performance is -36.26% and yearly performance percentage is -62.04%.
ILLEGAL ACTIVITY NOTICE: "Oppenheimer Holdings, Inc".
TRADEMARK VIOLATION WARNING: "Endo International PLC (ENDP) Raised to Sell at BidaskClub" was posted by BBNS and is owned by of BBNS. If you are viewing this story on another domain, it was stolen and republished in violation of United States and global copyright law. Also, COO Terrance J. Coughlin bought 20,000 shares of the firm's stock in a transaction dated Thursday, August 10th. The stock was acquired at an average cost of $7.70 per share, for a total transaction of $154,000.00. The company saw 0.51 million shares trade hands over the course of the day. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The shares were bought at an average price of $7.89 per share, with a total value of $51,285.00. Following the transaction, the chief executive officer now owns 213,620 shares in the company, valued at $1,647,010.20. OppenheimerFunds Inc. now owns 2,873,153 shares of the company's stock worth $32,065,000 after buying an additional 1,857,678 shares during the last quarter.More news: Analyst Research Roundup: HCA Healthcare, Inc. (HCA), Wells Fargo & Company
Several hedge funds and other institutional investors have recently bought and sold shares of ENDP. HL Financial Services LLC increased its stake in Endo International PLC by 1.0% in the second quarter.
The Relative Volume of the company is 2.36 and Average Volume (3 months) is 6.18 million.
Analyst mean recommendation on a stock by the analyst community is at 2.70. First Quadrant L P CA purchased a new stake in shares of Endo International PLC during the first quarter worth about $24,556,000. OppenheimerFunds Inc. increased its stake in Endo International PLC by 182.9% in the first quarter. Schneider Capital Management Corp now owns 642,311 shares of the company's stock worth $7,168,000 after buying an additional 83,100 shares during the last quarter. EPS breaks down the profitability of the company on a single share basis. Institutional investors and hedge funds own 92.27% of the company's stock.
Endo International plc, launched on October 31, 2013, is a generics and specialty branded pharmaceutical company.More news: Capture every PlayerUnknown's Battlegrounds kill automatically with ShadowPlay Highlights
- Scooter driver with eyes on phone rides right into sinkhole
- Sensex, Nifty open higher before shedding gains, Infosys stocks down by 2.7%
- North Korea vows "merciless retaliation" over US-South Korea military drills
- Premier League legend blasts Chelsea for 'ridiculous' piece of transfer business
- Torrei Hart Numbers Don't Lie Kevin Was Cheating on Me
- Bharti Airtel to counter Jiophone with "mass market" phone
- Police probe how many fell victim to cannibal
- Korea's Moon: There will be no war on Korean peninsula
- Do You Have Dash Cam Footage Of This Fatal Crash?
- Jets ordered McCown not to talk to media after game